| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.067 | 0.3 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.3 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.34 | 0.3 |